Biotech company Eradivir is developing lead drug EV25 to treat influenza

Purdue University

Jul 10, 2024

Eradivir, a preclinical biotech company, leverages small molecule targeting technology developed in Philip Low's lab at Purdue University to focus on a platform of immunotherapies…